Fulton Breakefield Broenniman’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-4,672
Closed -$481K 144
2020
Q3
$481K Sell
4,672
-100
-2% -$10.4K 0.05% 105
2020
Q2
$484K Buy
4,772
+1,708
+56% +$153K 0.06% 109
2020
Q1
$206K Buy
+3,064
New +$191K 0.03% 146

Other funds holding DXCM

Fulton Breakefield Broenniman's DXCM Position: Q4 2020 in Review

Fulton Breakefield Broenniman sold out of DexCom (DXCM) in Q4 2020, closing a stake of 4,672 shares — an estimated $481K sold.

Fulton Breakefield Broenniman first reported a position in DXCM in Q1 2020 and held it in 3 quarters. The position peaked at $484K in Q2 2020. 732 funds tracked by Wall St. Rank hold DXCM as of Q4 2020.

  • Fulton Breakefield Broenniman reported no remaining DexCom position as of Q4 2020 after selling out during the quarter.
  • Fulton Breakefield Broenniman sold 4,672 DexCom shares in Q4 2020, an estimated $481K.
  • Fulton Breakefield Broenniman first reported a position in DexCom in Q1 2020 and held it in 3 quarters.
  • Fulton Breakefield Broenniman's DexCom position peaked at $484K in Q2 2020.
  • 732 funds tracked by Wall St. Rank held DexCom as of Q4 2020.

Based on Fulton Breakefield Broenniman's 13F filing for Q4 2020, filed 14 Jan 2021.